Showing results for : lutetium 177 prostate cancer treatment

Radio-theranostics: How Tiny Radioactive Molecules are Personalising Cancer Care

The term 'theranostics' is an integration of the words 'therapeutics' and 'diagnostics'. Theranostic agents are paired agents, one an imaging agent that 'sees' the lesion and the other, a companion therapeutic agent that 'treats' the same lesions. While the concept of theranostics is widely used in various molecular probes in oncology, the most relevant application of theranostics is in nuclear medicine where it is called Radio-theranostics.

Read more
Lowest Cost of Lu177 PSMA Therapy

For prostate cancer patients who have become refractory to conventional therapy, the department of Nuclear Medicine & Molecular Imaging at the Fortis Memorial Research Institute (FMRI) in India’s Gurugram is not only one of the World’s most advanced Nuclear Medicine Centre but is also the centre that offers the lowest cost for Lu177 PSMA Therapy.

Read more